Pharmafile Logo

orphan medicines

Impetus Digital Fireside Chat with with Jon Sockell, Co-Founder/COO of Limbix

Jon Sockell, Co-founder and COO of Limbix, sits down with us in this Fireside Chat. See how Limbix is paving the way for prescription digital therapeutics and learn from their trials,...

Impetus Digital

Impetus Digital Systems Innovation Masterclass: Systems Change, Wicked Problems, and Multisolving

In this session, we discussed systems change, wicked problems, and multisolving. We reviewed the transformational changes that can evolve and go beyond "cause and effect" thinking. In this dialogue, we...

Impetus Digital

- PMLiVE

OPEN Health attend day 2 of the ECRD2020 congress

Gavin Jones is looking forward to sessions on innovation in advanced therapies and working towards equitable access.

OPEN Health

Impetus Digital Fireside Chat with Esther Schorr from Patient Power LLC

Esther Schorr, Co-founder and Chief Operating Officer of Patient Power, discusses her non-linear journey to patient education and Patient Power's mission to empower patients and their loved ones to take control...

Impetus Digital

Impetus Digital Fireside Chat with Jim Lefevere from Roche

Jim Lefevere from Roche, discusses the changes in digital marketing strategies, workflow, team dynamics, and required skill sets among Pharma teams brought on by COVID-19. We also touch on the slow but...

Impetus Digital

- PMLiVE

OPEN Health discuss Global Community in Rare Disease

Annie Rankin how we can work smarter with healthcare professionals

OPEN Health

- PMLiVE

AMICULUM® launches new specialist agency: AMICULUM Access

AMICULUM Access is a full-service market access agency bringing together existing in-house market access expertise from across AMICULUM’s agencies to provide a consolidated service to both new and existing clients.

AMICULUM

Virtualizing In-person Meetings with the Impetus InSite Platform®

Natalie Yeadon sits down with Mark Corrigan from Impetus Digital to discuss best practices when transferring in-person meetings online.

Impetus Digital

- PMLiVE

Chiesi launches new rare disease R&D division

New business unit will be based in Boston, US

Sanofi reception

Sanofi’s rare disease drug olipudase alfa scores in late-stage study

Met crucial endpoints across two clinical studies

- PMLiVE

OPEN Health expands global footprint with Pharmerit International integration

Global health comms and market access group now has presence in six countries

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links